BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Brimonidine Tartrate; Metronidazole; Niacinamide; Ivermectin.
| Product ID | 72934-1028_88f00580-a0ca-168f-e053-2a95a90a6e4b |
| NDC | 72934-1028 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% |
| Generic Name | Brimonidine Tartrate 0.25% / Ivermectin 1% / Metronidazole 1% / Niacinamide 4% |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-16 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | BRIMONIDINE TARTRATE; METRONIDAZOLE; NIACINAMIDE; IVERMECTIN |
| Active Ingredient Strength | 0 g/100g; g/100g; g/100g; g/100g |
| Pharm Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC],Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS],Antiparasitic [EPC],Pediculicide [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |